Nitric oxide modulation of endothelium-derived hyperpolarizing factor in agonist-induced depressor responses in anesthetized rats

European Journal of Pharmacology

Volumn 762, Issue , 2015, Pages 26-34

  Kobuchi, Shuhei ^a,b   Miura, Katsuyuki ^b   Iwao, Hiroshi ^b,c   Ayajiki, Kazuhide ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c International Buddhist University   (Japan)

Author keywords

Ca^{2+< sup> activated K+< sup> channel; cGMP; Endothelium derived hyperpolarizing factor (EDHF); Gap junction; Nitric oxide (NO)}

Indexed keywords

8 BROMO CYCLIC GMP; ACETYLCHOLINE; APAMIN; BARIUM CHLORIDE; BRADYKININ; CARBENOXOLONE; CATALASE; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FAMPRIDINE; GLIBENCLAMIDE; IBERIOTOXIN; INDOMETACIN; MEPACRINE; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OUABAIN; PHENYLEPHRINE; POTASSIUM CHANNEL; SALBUTAMOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DEPRESSOR RESPONSE; GAP JUNCTION; HYPERPOLARIZATION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; ANESTHESIA; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANESTHESIA; ANIMALS; BIOLOGICAL FACTORS; BLOOD PRESSURE; BRADYKININ; DRUG INTERACTIONS; INDOMETHACIN; MALE; NITRIC OXIDE; NITROARGININE; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 84930194615     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.04.053     Document Type: Article

References (51)

1. K. Ayajiki, H. Fujioka, K. Shinozaki, and T. Okamura Effects of capsaicin and nitric oxide synthase inhibitor on increase in cerebral blood flow induced by sensory and parasympathetic nerve stimulation in the rat J. Appl. Physiol. 98 2005 1792 1798
2. J. Bauersachs, R. Popp, M. Hecker, E. Sauer, I. Fleming, and R. Busse Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor Circulation 94 1996 3341 3347
3. E.J. Behringer, M.J. Socha, L. Polo-Parada, and S.S. Segal Electrical conduction along endothelial cell tubes from mouse feed arteries: confounding actions of glycyrrhetinic acid derivatives Br. J. Pharmacol. 166 2012 774 787
4. T. Berg, and O. Koteng Signalling pathways in bradykinin- and nitric oxide-induced hypotension in the normotensive rat; role of K+-channels Br. J. Pharmacol. 121 1997 1113 1120
5. R.M. Bryan, J. You, E.M. Golding, and S.P. Marrelli Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin Anesthesiology 102 2005 1261 1277
6. I.L. Buxton, D.J. Cheek, D. Eckman, D.P. Westfall, K.M. Sanders, and K.D. Keef NG-Nitro l-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists Circ. Res. 72 1993 387 395
7. P.S. Chadha, L. Liu, M. Rikard-Bell, S. Senadheera, L. Howitt, R.L. Bertrand, T.H. Grayson, T.V. Murphy, and S.L. Sandow Endothelium-dependent vasodilation in human mesenteric artery is primarily mediated by myoendothelial gap junctions intermediate conductance calcium-activated K+ channel and nitric oxide J. Pharmacol. Exp. Ther. 336 2011 701 708
8. Y. Cheng, J.F. Ndisang, G. Tang, K. Cao, and R. Wang Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats Am. J. Physiol. Heart Circ. Physiol. 287 2004 H2316 H2323
9. A.N. Chepkova, O.A. Sergeeva, and H.L. Haas Carbenoxolone impairs LTP and blocks NMDA receptors in murine hippocampus Neuropharmacology 55 2008 139 147
10. M.S. Chintala, V. Bernardino, and P.J. Chiu Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats J. Pharmacol. Exp. Ther. 271 1994 1203 1208
11. G.J. Christ, D.C. Spray, M. El-Sabban, L.K. Moore, and P.R. Brink Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone Circ. Res. 79 1996 631 646
12. A.S. De Vriese, J. Van de Voorde, and N.H. Lameire Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation Kidney Int. 61 2002 177 185
13. K.M. Desai, V. Gopalakrishnan, L.M. Hiebert, J.R. McNeill, and T.W. Wilson EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats Eur. J. Pharmacol. 546 2006 120 126
14. C. De Wit, N. Esser, H.a. Lehr, S.S. Bolz, and U. Pohl Pentobarbital-sensitive EDHF comediates ACh-induced arteriolar dilation in the hamster microcirculation Am. J. Physiol. 276 1999 H1527 H1534
15. C. De Wit, and T.M. Griffith Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses Pflügers Arch. 459 2010 897 914
16. J.M. Doughty, J.P. Boyle, and P.D. Langton Potassium does not mimic EDHF in rat mesenteric arteries Br. J. Pharmacol. 130 2000 1174 1182
17. A.J. Edgley, M. Tare, R.G. Evans, C. Skordilis, and H.C. Parkington In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 2008 R829 R839
18. G. Edwards, K.A. Dora, M.J. Gardener, C.J. Garland, and A.H. Weston K+ is an endothelium-derived hyperpolarizing factor in rat arteries Nature 396 1998 269 272
19. G. Edwards, M. Félétou, M.J. Gardener, C. Thollon, P.M. Vanhoutte, and A.H. Weston Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries Br. J. Pharmacol. 128 1999 1788 1794
20. M. Félétou, and P.M. Vanhoutte Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler. Thromb. Vasc. Biol. 26 2006 1215 1225
21. M. Félétou, and P.M. Vanhoutte EDHF: an update Clin. Sci. (Lond) 117 2009 139 155
22. M. Félétou The Endothelium: Part 2: EDHF-Mediated Responses "The Classical Pathway" 2011 Morgan & Claypool Life Sciences Publisher San Rafael, CA
23. X.F. Figueroa, and B.R. Duling Dissection of two Cx37-independent conducted vasodilator mechanisms by deletion of Cx40: electrotonic versus regenerative conduction Am. J. Physiol. Heart. Circ. Physiol. 295 2008 H2001 H2007
24. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, I. Fleming, and R. Busse Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
25. H. Fujioka, K. Ayajiki, K. Shinozaki, N. Toda, and T. Okamura Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries Naunyn Schmiedebergs Arch. Pharmacol. 366 2002 488 495
26. S. Gigout, J. Louvel, and R. Pumain Effects in vitro and in vivo of a gap junction blocker on epileptiform activities in a genetic model of absence epilepsy Epilepsy Res. 69 2006 15 29
27. T.M. Griffith Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br. J. Pharmacol. 141 2004 881 903
28. A. Huang, D. Sun, A. Jacobson, M.A. Carroll, J.R. Falck, and G. Kaley Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle Circ. Res. 96 2005 376 383
29. J.C. Irvine, J.L. Favaloro, and B.K. Kemp-Harper NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries Hypertension 41 2003 1301 1307
30. P. Kessler, R. Popp, R. Busse, and V.B. Schini-Kerth Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism Circulation 99 1999 1878 1884
31. V. Leuranguer, P.M. Vanhoutte, T. Verbeuren, and M. Félétou C-Type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery Br. J. Pharmacol. 153 2008 57 65
32. M. Malmsjö, A. Bergdahl, X.H. Zhao, X.Y. Sun, T. Hedner, L. Edvinsson, and D. Erlinge Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF- dilatation in congestive heart failure Cardiovasc. Res. 43 1999 200 209
33. T. Matoba, H. Shimokawa, M. Nakashima, Y. Hirakawa, Y. Mukai, K. Hirano, H. Kanaide, and A. Takeshita Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice J. Clin. Invest. 106 2000 1521 1530
34. Y. Nishikawa, D.W. Stepp, and W.M. Chilian Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo Am. J. Physiol. Heart Circ. Physiol. 279 2000 H459 H465
35. M. Ozkor, and A. Quyyumi Endothelium-derived hyperpolarizing factor and vascular function Cardiol. Res. Pract. 2011 2011 156146
36. K. Pogoda, M. Füller, U. Pohl, and P. Kameritsch NO, via its target Cx37, modulates calcium signal propagation selectively at myoendothelial gap junctions Cell Commun. Signal. 12 2014 33
37. H.C. Parkington, J.A. Chow, R.G. Evans, H.A. Coleman, and M. Tare Role for endothelium-derived hyperpolarizing factor in vascular tone in rat mesenteric and hindlimb circulations in vivo J. Physiol. 542 2002 929 937
38. B. Rodenwaldt, U. Pohl, and C de Wit Endogenous and exogenous NO attenuates conduction of vasoconstrictions along arterioles in the microcirculation Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2341 H2348
39. N.M. Rummery, and C.E. Hill Vascular gap junctions and implications for hypertension Clin. Exp. Pharmacol. Physiol. 31 2004 659 667
40. G.D.V. Sagar, and D.M. Larson Carbenoxolone inhibits junctional transfer and upregulates Connexin43 expression by a protein kinase A-dependent pathway J. Cell. Biochem. 98 2006 1543 1551
41. H. Shimokawa, H. Yasutake, K. Fujii, M.K. Owada, R. Nakaike, Y. Fukumoto, T. Takayanagi, T. Nagao, K. Egashira, M. Fujishima, and A. Takeshita The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation J. Cardiovasc. Pharmacol. 28 1996 703 711
42. W.S. Shin, T. Sasaki, M. Kato, K. Hara, A. Seko, W.D. Yang, N. Shimamoto, T. Sugimoto, and T. Toyo-oka Autocrine and paracrine effects of endothelium-derived relaxing factor on intracellular Ca2+ of endothelial cells and vascular smooth muscle cells. Identification by two-dimensional image analysis in coculture J. Biol. Chem. 267 1992 20377 20382
43. G.J. Smits, M.H. Perrone, and B.F. Cox Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats J. Cardiovasc. Pharmacol. 29 1997 49 56
44. O. Sofola, A. Knill, R. Hainsworth, and M. Drinkhill Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet J. Physiol. 543 2002 255 260
45. S.O. Suadicani, C.F. Brosnan, and E. Scemes P2×7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling J. Neurosci. 26 2006 1378 1385
46. N. Thengchaisri, and L. Kuo Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels Am. J. Physiol. Heart Circ. Physiol. 285 2003 H2255 H2263
47. K. Thomsen, I. Rubin, and M. Lauritzen In vivo mechanisms of acetylcholine-induced vasodilation in rat sciatic nerve Am. J. Physiol. Heart Circ. Physiol 279 2000 H1044 H1054
48. G.J. Waldron, H. Ding, F. Lovren, P. Kubes, and C.R. Triggle Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase Br. J. Pharmacol. 128 1999 653 658
49. Z.H. Zhang, Y.M. Kang, Y. Yu, S.G. Wei, T.J. Schmidt, A.K. Johnson, and R.B. Felder 11beta-Hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation Hypertension 48 2006 127 133
50. M.H. Zink, C.L. Oltman, T. Lu, P.V. Katakam, T.L. Kaduce, H. Lee, K.C. Dellsperger, A.A. Spector, P.R. Myers, and N.L. Weintraub 12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation Am. J. Physiol. Heart Circ. Physiol. 280 2001 H693 H704
51. P.M. Zygmunt, G. Edwards, H. Weston, B. Larsson, and E.D. Högestätt Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery Br. J. Pharmacol. 121 1997 141 149